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Thin GBM nephropathy: Premature glomerular obsolescence is asso-
ciated with hypertension and late onset renal failure. Thin glomerular
basement membrane (GBM) nephropathy, also called familial benign
hematuria, is characterized by chronic hematuria and uniform thinning of
the lamina densa of the glomerular basement membrane. It generally
holds an excellent renal prognosis. Alport syndrome in early stages can
also show attenuation of the GBM; conversely, renal insufficiency has been
reported in familial benign hematuria. To discern early Alport syndrome
from thin GBM nephropathy, we carried out a prospective epidemiolog-
ical study in which 19 normotensive and non-azotemic adult patients with
chronic microscopic (18 of 19) and macroscopic (1 of 19) hematuria and
biopsy-proven thin GBM nephropathy were followed for a median of 12
years (range 9 to 15 years). Renal biopsies of thin GBM patients at entry
showed an increased incidence of focal global glomerulosclerosis when
compared to disease controls as IgA nephropathy (P = 0.047) and normal
renal tissue (P = 0.0075). All renal biopsies showed the presence of the
Goodpasture antigen when tested immunohistochemically. Presence of
Alport syndrome was excluded clinically as none of the patients had
complaints of hearing loss or abnormalities by audiography and ophthal-
mology. At the end of follow-up, the incidence of hypertension in thin
GBM nephropathy (35%) exceeded that of healthy clinical controls (P =
0.048), and one hypertensive patient developed mild renal failure. In the
normotensive patients, the glomerular filtration rate at follow-up as
measured by inulin clearance was reduced in three out of seven; these
were over 50 years of age. Although no family members were known to
have renal disease at inclusion, within four families six elderly first degree
relatives had developed unexplained renal insufficiency at the end of
follow-up. Thus, thin GBM nephropathy predisposes to premature gb-
merular obsolescence, leading in time to increased incidences of hyper-
tension and late onset renal insufficiency.
Thin glomerular basement membrane (GBM) nephropathy,
so-called benign familial hematuria, refers to patients with chronic
hematuria, usually of the microscopic variety, is equally distrib-
uted over the sexes, and carries an excellent short-term renal
prognosis [1]. The diagnosis is made by means of quantitative
ultrastructural morphometry that shows a uniform thinning of the
lamina densa of the glomerular basement membranes. Silver
impregnation staining of these biopsies reveals thinning, local
reduplication and a moth-eaten mesangial matrix, all considered
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to be minor glomerular changes [2]. Clinically, thin GBM ne-
phropathy and the progressive renal hereditary disorder Alport
syndrome appear to be distinct entities, although in individual
cases, particularly in children, the differentiation may be difficult
as the histological changes cited above may also be seen in early
Alport syndrome [31. Also, renal insufficiency has been observed
occasionally in thin GBM nephropathy [4, 5]. In Alport syndrome,
different clinical manifestations are recognized and juvenile and
adult-onset renal insufficiency are distinguished [6]. The mode of
inheritance is most often X-linked, occasionally autosomal reces-
sive or, rarely, autosomal dominant. In Alport syndrome immu-
nohistochemical studies have implicated collagen type IV in the
pathogenesis, and several causative mutations have been identi-
fied in different type IV collagen genes [reviewed in 71. Recently,
Smeets et al [81 detected a missense mutation in collagen type IV
in benign familial hematuria, which raises the question of whether
or not thin GBM nephropathy is an atypical form of Alport
syndrome. We addressed this question by a long-term follow-up of
normotensive adults with thin GBM nephropathy and appropriate
clinical controls in a prospective epidemiological study on idio-
pathic hematuria. None of the patients were known to have
familial renal disease at entry into the study, but follow-up showed
most of the thin GBM nephropathy patients to have familial
hematuria with an increased incidence of renal insufficiency in
first degree relatives.
Patients
Patients derived from a prospective epidemiological study of
idiopathic glomerular disease carried out between 1978 and 1984
[1]. Briefly, renal biopsies were taken from patients between 16
and 65 years of age, provided systemic extrarenal disease or
known familial renal disorders were absent. The indications for
renal biopsy included, in hierarchical order: recent onset uremia
(serum creatinine > 300 j.mol/liter), recent onset nephrotic
syndrome (proteinuria > 5 glday, in the absence of Bence Jones
proteinuria), recent onset hematuria with proteinuria and mild
azotemia, chronic non-urological hematuria of the persistent
microscopic or recurrent macroscopic variety with or without
proteinuria (> 250 mg/day), and chronic proteinuria in the
absence of hypertension. In the present study, renal biopsies were
taken from normotensive non-azotemic patients with idiopathic
chronic hematuria of six months duration. Twenty-seven patients
were shown to have primary IgA nephropathy, 24 patients had
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normal renal tissue and 19 patients were diagnosed as thin
glomerular basement nephropathy patients. Patients were biop-
sied because of non-urological microscopic or macroscopic hema-
tuna, in the absence of gross proteinuria. Biopsies were taken
within two years after patient identification. Persistent erythrocy-
tuna was defined as the consistent presence of more than 5
erythrocytes per high power field of centrifuged urine. All patients
had a normal blood pressure, none had increased serum creati-
nine concentrations and in all patients urologic examination was
negative. Patients with systemic disease, Henoch Schönlein ne-
phritis, liver disease or patients from families with known hered-
itary nephritis were excluded from the study. None of the patients
with thin GBM disease was consanguineous or had knowledge of
familial hematuria at the time of renal biopsy. All patients were
followed for a median period of 12 years (range 9 to 15 years).
Signs of disease progression were development of hypertension
(> 140/90 mm Hg), increase in proteinuria (at least 0.5 g/day at
follow-up), or development of uremia (serum creatinine concen-
tration > 140 smol/1iter). In three patients repeat renal biopsies
were taken to determine the histological substrate for disease
progression.
Renal biopsies
Renal biopsies were processed for light microscopy, immuno-
fluorescence and ultrastructural analysis as described elsewhere
[9]. Renal biopsies were classified according to the criteria as
defined by the World Health Organization [3]. Glomerular base-
ment membrane thickness was determined by the method of
Steffes et al [10]; using this method in adults a value of less than
260 nm is diagnostic for thin glomerular basement membranes [1].
The extent of focal global glomerulosclerosis in renal biopsies of
all patients presenting with idiopathic hematuria was determined
by counting the total number of glomeruli and the amount of
sclerosed glomeruli in at least five consecutive 2 tm sections—
selected for their highest amount of glomeruli per section (range
of glomeruli per section 12 to 41)—stained with silver methena-
mm hematoxylin eosin. In addition, 2 sm thick cryosections were
stained in an indirect immunofluorescence assay for presence of
the putative Goodpasture antigen with a mouse monoclonal
antibody (mAb 17) against the non-collagenous domain of the
a3-chain of collagen type 4 (provided by J. Wieslander, Biocarb,
Denmark). Binding of the monoclonal antibody was visualized
with a 1 to 100 dilution of a polyclonal goat anti-mouse Ig-FITC-
labeled antibody (Organon Teknica Cappel, Boxtel, The Nether-
lands). As positive controls, sections of normal renal tissue were
tested.
Tone and speech audiograms were obtained from 10 thin GBM
patients, performed by a trained audiometrist. These patients
were also subjected to a slit-lamp and fundoscopy examination
performed by a trained ophthalmologist. Development of hyper-
tension and decreased GFR was equally divided over the patients
that were tested with audiograms and those that were not tested.
Proteinunia was determined at initial biopsy and at follow-up in a
24 hour urine specimen. Protein content was measured with a
biuret assay, and adequate sampling was verified by measuring
creatinine excretion in an automated creatinine analyzer based on
the Jaffe reaction. When patients had proteinunia in excess of 200
mg/day orthostatic proteinunia was ruled out by overnight collec-
tions. Aliquots of urine were dialyzed against water, lyophilized
and stored at 4°C. When desired, equal fractions of this lyophi-
Table 1. Family history in thin GBM nephropathy and primary IgA
nephropathy
Thin GBM
nephropathy
IgA
nephropathy
Family history available 16 25
Number of parents
in renal failure°
32
3
50
1
Number of siblings
in renal failure°
57
3
79
0
Total first degree relatives
in renal failure°
89
6
129
1b
° Renal failure was defined as serum creatinine concentration over 300
mol/literb Fisher exact test: P 0.019
lized urine were subjected to gradient electrophoresis in order to
determine the type of proteinuria.
Statistics
Statistical calculations were performed on a SPSS program for
the Apple computer. When absolute numbers were compared, the
chi square test with the Fisher exact correction was used. Com-
parison between IgA nephropathy, thin GBM nephropathy and
normal renal tissue were performed using the Mann Whitney rank
test.
Renal function studies
Creatinine clearances were calculated using the Cockroft for-
mula [GFR (140 — age) x weight/serum creatinine (mg/dl) X
72; for females the result was multiplied with 0.85]. GFR and
ERPF values were determined using a continuous infusion of
inulin and paraaminohippunic acid. For determination of GFR
and ERPF patients were examined in a supine position, and
adequate diuresis was ensured by oral intake of 200 to 300 ml
water per hour. A blood blank was drawn and a priming dose of
500 mg/rn2 PAH (Aminohippurate sodium; MSD, West Point,
PA, USA) and 1000 mg/rn2 inulin (mutest; Laevosan Gesellschaft,
Linz, Austria) was prepared, of which 80% was given in a bolus
and the remainder at a flow rate of 100 mI/hr. This was followed
by a continuous infusion of PAH and inulin, while the infusion
rate was adapted to the estimated renal function. An equilibration
time of 120 minutes was used, and subsequently four blood
samples were drawn every 10 minutes. PAH was determined
spectrophotometnically according to Brun [11]; inulin was deter-
mined spectrophotometrically as glucose after full enzymatic
hydrolysis of fructose [12]. We only tested the normotensive thin
GBM patients to avoid confounding of the effects of hypertension
and therapy for hypertension on GFR and ERPF.
Results
Family history in thin GBM nephropathy
At the time of renal biopsy all patients with thin GBM
nephropathy were considered to be isolated cases of idiopathic
chronic hematunia, but careful history taking and family research
at follow-up revealed that hematuria, proteinuria and/or impaired
renal function was present in the families of 9 of 16 patients (in 3
cases no data on the family history were available). Within four
families, six elderly first-degree relatives of the index patients were
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Fig. 1. Two ftmily pedigrees depicting the mode of inheritance in thin GBM nephropathy. The open symbols or '?' represent untested individuals, the
unaffected individuals are indicated by a 'N'. The hematuric individuals are indicated with a semi-filled symbol, while hematuric and proteinuric
individuals are indicated with a three-quarterly filled symbols. Renal insufficiency is indicated with a black symbol, the deceased individuals are
represented with a slash through the symbol. Squares represent males, while circles represent females. Arrows refer to renal biopsy proven thin GBM
nephropathy.
identified who had end-stage renal disease necessitating dialysis
(Table 1). Of these elderly family members, aged between 55 and
67 years, no renal biopsy specimens were available. At the time of
presentation they all had moderate to severe renal failure with
microscopic hematuria, proteinuria and hypertension. The mode
of inheritance in these families appeared to be autosomal domi-
nant (Fig. I). Similarly, the family history in 25 IgA nephropathy
patients who were hiopsied for idiopathic hematuria was exam-
ined. A positive family history for renal failure was present in one
instance, while familial hematuria was identified in another family
(Table 1). Of the 24 patients with normal renal tissue, none had
family members with renal insufficiency.
Follow-up of thin GBM nephropathy
During the 12-year follow-up period two patients died due to
pancreatic and lung carcinoma, and therefore no renal data were
obtained from them. Nine patients showed clinical signs sugges-
tive of progressive renal disease, and seven patients developed
hypertension with increased proteinuria associated in two and
mild renal insufficiency (creatinine concentration of 150 .rmo!/
liter) in one. Two other patients developed increased proteinuria
(0.6 and 1.6 g!day) in the absence of hypertension. In all but one
patient with thin GBM nephropathy, protcinuria was of the
non-selective variety, both at the time of renal biopsy and at the
end of follow-up. Of the hypertensives, six out of seven were male,
while increased proteinuria was seen two out of the eight females.
In the normal renal tissue group, two patients developed essential
hypertension with a positive family history for hypertension; one
patient developed increased proteinuria, which preceded the
diagnosis of type II diabetes mellitus (Table 2). The incidences of
hypertension and increased proteinuria were comparable to those
in IgA nephropathy. Flowever, in IgA nephropathy three patients
progressed to renal failure, necessitating renal replacement ther-
apy in one. Creatinine clearances in the thin GBM group.
calculated by the Cockroft formula, showed no significant change
during the follow-up (creatinine clearance at initial biopsy was
98 18 ml/min/l.73 m2 and at follow-up was 92 17 ml/min/1.73
m2). GFR and ERPF were determined in seven out of 10 patients
who had remained normotensive at the end of follow-up. GFR
was shown to be reduced in three patients over 50 years of age
when compared to age matched controls. Similarly, ERPF was
slightly lower than expected in these patients compared to normal
controls (Fig. 2).
In the initial rena! biopsies of thin GBM nephropathy an
increased percentage of focal global glomerulosclerosis was al-
ready present (Table 2), which was confirmed in the repeat renal
biopsies that were taken from three patients who had shown
development of hypertension (I X), increase in proteinuria (lx)
A
III: 15 111:16 III: 17 111:18 III: 19 111:20 111:21 111:22 111:23 111:24
B
LJLJ
IV:1 IV:2
Nieuwhof et at: Family history in thin GBM nephropathy 1599
Thin GBM
nephropathy
IgA
nephropathy
Normal
renal tissue
Clinical presentation
No. patients 19 27 24
Mean age years 36 31 32
Male:female ratio 10:9 20:7 21:3
Isolated hematuria 14 7 18
Hematuria + proteinuria' 5 20 6
Histology at entry
Total glomeruli/coupe 18 7 14 35 16 10
Focal global 13.5 17% 5.1 7.3%' 3.1 4.4%
glomerulosclerosis
GBM thickness nm 191 28 345 55 361 69
Follow-up
No. patients l7 27 24
Hypertensivee 6 (1) 8 (3) 2 (0)
Increased proteinuria 2 3 1
Increased serum creatinine 1 3 (1) 0
a Protein excretion > 250 mg/day
Total number of glomeruli: IgA nephropathy vs. thin GBM nephrop-
athy, P = 0.059; IgA nephropathy vs. normal renal tissue, P = 0.17; thin
GBM nephropathy vs. normal renal tissue, P = 0.37
Focal global glomerulosclerosis: thin GBM nephropathy vs. IgA, P
0.047; thin GBM nephropathy vs. normal renal tissue, P = 0.0075
dTwo patients with thin GBM nephropathy had died during follow-up
due to pancreatic and lung carcinoma
a Between parenthesis are mentioned the proteinuric hypertensives
Increased serum creatinine concentration over 140 j.rmol/liter, be-
tween parenthesis are mentioned the end-stage renal failure patients
or development of renal insufficiency (lx). In these repeat renal
biopsies increased focal global glomerulosclerosis with tubular
atrophy and interstitial fibrosis was present, without lesions of
active interstitial infiltrate, focal and segmental glomerulosclerosis
or foam cells (Fig. 3). Persistent thinning of the GBM in an
unimodal distribution was present ultrastructurally, with only
local reduplication and splitting, histologically.
Differentiation from Alport syndrome
None of the patients with thin GBM nephropathy suffered from
subjective hearing loss or vision problems. Audiograms and
ophthalmologic examination showed that none of the patients had
signs of sensorineural hearing loss, anterior lenticonus or macular
changes. Furthermore, all renal biopsies of the thin GBM patients
were stained for the presence of the NCI-domain of the a3-chain
of collagen type IV. All patients showed diffuse intense glomer-
ular capillary linear staining with variable intensity of tubular
staining, illustrating presence of the Goodpasture antigen. The
staining pattern was similar to that seen in eighteen patients with
normal renal tissue on biopsy.
Discussion
The main findings of this study were fourfold. First, field studies
showed the majority of the patients with apparently non-familial
erythrocyturia to be in fact of the familial variety. Second, thin
GBM nephropathy was associated with a significantly higher
incidence of renal insufficiency in the first degree relatives and
with an increased incidence of focal global glomerulosclerosis
when compared patients with idiopathic IgA nephropathy and
with normal renal tissue associated with hematuria. Third, the
twelve year follow-up revealed an incidence of hypertension
comparable to that in patients with idiopathic non-azotemic IgA
200
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Fig. 2. Determination of GFR (A) and ERPF (B) in normotensive thin
GBM nephropathy, as measured with inulin and PAH clearances, compared
to healthy subjects. Symbols are: (0) GFR and ERPF measurements in
healthy subjects between 33 and 67 years of age; (S) GFR and ERPF data
in the normotensive thin GBM patients that were available for renal
function studies. GFR is reduced in three elderly thin GBM nephropathy
patients, in one patient ERPF also clearly is lower than in the normal
subjects. The middle line represents the linear regression line, the Outer
lines represent the upper and lower 95% confidence intervals. Multiple
regression analysis showed the GFR regression line of thin GBM patients
to differ significantly from the healthy controls (P = 0.022); the ERPF
regression lines are not different (P = 0.37).
Table 3. GFR and ERPF measurements in normotensive thin
glomerular basement rephropathy patients at the end of follow-up
Thin GBM nephropathy Normal subjects
Scxage GFR ERPF FF GFRERPF
No. (yr) ml/min/1.73 m2 ml/min/1.73 m2
no. I f/35 117 531 0.22 (age 33—47 years, N = 11)
no. 2 f/38 116 409 0.28 113 11 414 70
no. 3 f/38 96 429 0.22
no. 4 f/48 102 358 0.28 (age 52—67 years, N = 6)
no. 5 f/SI 79 322 0.25 97 13 404 59
no. 6 f/58 79 357 0.22
no. 7 m/61 64 251 0.25
nephropathy and showed a decline in renal function in three
elderly patients. Finally, none of the thin GBM patients developed
sensorineural hearing loss.
The familial nature of hematuria in thin GBM nephropathy has
been described previously [2, 4, 5, 13—171. Since the hematuria is
usually of the microscopic variety and renal failure occurs only in
Table 2. Clinical presentation and follow-up in thin GBM nephropathy
and hematuric controls
-a
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GFR and ERPF were determined using inulin and paraaminohippuric
acid clearances.
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Fig. 3. Thin GBM nephropathy, silver methenamin hematoxylin eosin staining (magnification x200). Repeat renal biopsy, taken because of hypertension
and increased serum creatinine. Note the diffuse focal global glomerulosclerosis, as indicated with arrowheads, tubular atrophy and interstitial fibrosis.
elderly family members, none of the thin GBM patients in the
present study, of whom the mean age at entry was 36 years, was
aware of the familial nature at the time of renal biopsy. It should
be noted that of our thin GBM patients five presented with
significant proteinuria (> 250 mg/day), while this increased during
follow-up in another two. The origin of the increase in proteinuria
in the absence of hypertension is not clear. In some of the thin
GBM nephropathy patients, not belonging to the present series,
increased proteinuria is associated with the presence of focal and
segmental glomerulosclerosis in the renal biopsy (unpublished
observation). Renal failure, either in patients with thin GBM
nephropathy or in first degree relatives has only been reported
occasionally [4, 5], but the high incidence of renal insufficiency in
elderly first degree relatives as seen in our study has not been
described previously. We could not find an increased prevalence
of renal disease in our population of IgA nephropathy patients,
contrary to experience of others [18].
During follow-up hypertension developed in more than one
third of the patients, while proteinuria increased in an additional
two. Interestingly, although males and females were equally
affected by thin GBM nephropathy, hypertension was more
prevalent in males while increased proteinuria occurred only in
females. This predominance of males with hypertension was not
seen in our patients with IgA nephropathy, but corresponds to the
findings in both a large study of hypertension in patients with
glomerulonephritis [19] and to the increased prevalence of hyper-
tension in men in the general population [20]. In a recent study of
hematuric patients with thin and ultrathin GBM, in which the
criteria for diagnosis of thin GBM nephropathy were different
from our study, 14% presented with hypertension, while 28% had
proteinuria [21]. Reduced renal function was found in three
normotensive thin GBM patients over 50 years of age as illus-
trated by a decreased GFR and ERPF, one other patient showed
an increased serum creatinine concentration. We postulate that
the increased incidence of hypertension, development of protein-
uria and decreased GFR and ERPF is related to the increased
degree of focal global glomerulosclerosis as seen in the initial
biopsy and repeat renal biopsies of the thin GBM patients. The
fact that decreases in GFR and ERPF were seen in patients who
had remained normotensive, suggest that a renal substrate is
responsible for the loss in renal function. Histologically, focal
global glomerulosclerosis with tubular atrophy and interstitial
fibrosis appears a likely substrate. Thus, the prognosis of thin
GBM nephropathy may not be as benign as generally thought [2,
13] and, given the incidence of the disease in The Netherlands [9],
may be a cause of end-stage renal disease in a significant portion
of elderly patients.
Clinically, thin GBM nephropathy and Alport syndrome appear
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distinct entities, although in individual cases, especially in chil-
dren, the differentiation between Alport and thin GBM nephrop-
athy can be difficult since Alport syndrome can present with
uniform thinning of the GBM. In Alport syndrome, different
clinical manifestations are recognized and juvenile and adult
onset end-stage-renal disease are distinguished. The juvenile form
is said to exist if end-stage-renal-disease occurs before 31 years of
age. Atkin, Gregory and Border [61 classified the disease in six
types with dominant inheritance: type I is dominant juvenile
Alport associated with deafness, either X-linked or autosomal,
type II is X-linked dominant juvenile associated with deafness,
type III is X-linked dominant adult associated with deafness, type
IV is X-linked adult without deafness or other extrarenal symp-
toms, type V is autosomal with deafness and macrothrombocyto-
pathy and type VI is autosomal dominant juvenile with deafness.
For the diagnosis of Alport syndrome four criteria have been
defined, three of which have to be present to allow the diagnosis:
(1) positive family history of hematuria or chronic renal failure,
(2) electron microscopic evidence of Alport syndrome on renal
biopsy, (3) progressive high tone sensorineural deafness and (4)
characteristic eye symptoms [22]. Our thin GBM nephropathy
patients fulfilled only one or two criteria of this classification.
Furthermore, in all our patients the cr3 collagen type IV chain was
demonstrable in immunofluorescence studies of frozen biopsies.
Repeat renal biopsies in thin GBM nephropathy, taken after a
median disease history of 10 years, showed persistent thinning of
the GBM in a unimodal distribution, with only local reduplication
and splitting; foam cells were not seen in these biopsies. Thus, thin
GBM nephropathy resembles Alport syndrome in terms of
chronic, often familial, erythrocyturia, but lacks the extrarenal
symptoms of Alport syndrome. It may share some of the ultra-
structural GBM features, but does not fulfil the diagnostic criteria
for Alport syndrome.
Biopsies of thin GBM nephropathy show extreme attenuation
of the lamina densa, which is built up from collagen type IV, a
triple helix collagen incorporating differing combinations of the
al(IV)-a5(IV) chains. The genes involved in collagen type IV
synthesis are therefore good candidates for genetic analysis.
Savige [16] excluded linkage of thin GBM nephropathy with the
collagen type IV cr1 and cr2 chains. Lemmink et al, using
intragenic COL4A3/COL4A4 markers, recently detected a mis-
sense mutation in the COL4A4 gene in a family with benign
familial hematuria, of which the propositus showed thinning of
the GBM and focal and segmental GBM abnormalities [8].
Thus, although thin GBM nephropathy is clinically different
from Alport syndrome, both thin GBM nephropathy and Alport
syndrome appear to result from defects in collagen type IV coding
genes. Hence, thin GBM nephropathy and Alport syndrome may
represent two extremes of the spectrum of collagen type IV gene
disorders. Thin GBM nephropathy predisposes to premature
glomcrular obsolescence, hypertension and increased incidence of
late onset renal insufficiency.
Acknowledgments
This study was financially supported by the Dutch Kidney Foundation,
grant number C 89.929. Mr. H. van Rie provided technical assistance. The
GFR/ERPF determinations were performed by P. van Es and M. Fuss.
Reprint requests to Prof P.J. C. van Breda Vriesman, Rijksuniversiteit
Limburg, Department of Immunology, P.O. Box 616, 6200 MD Maastricht,
The Netherlands.
References
1. TIEB05cH A, FREDERIK P, VAN BREDA VRIESMAN P, Mooc J, VAN RIE
H, VAN DE WIEL T, WOLTERS J, ZEPPENFELDT E: Thin-basement-
membrane nephropathy in adults with persisting hematuria. N EngI
J Med 320:14—18, 1989
2. SAXENA S, DAVIES D, KIRSNER R: Thin basement membranes in
minimally abnormal glomeruli. J Clin Pathol 43:32—38, 1990
3. CI-IURG J, BERNSTEIN J, GLASSOCK R: Renal Disease (2nd ed). Tokyo-
New York, Igaku-Shoin, 1995
4. TRACHTMAN H, WEISS R, BENNETr B, GREIFER I: Isolated hematuria in
children: Indications for a renal biopsy. Kidney mt 25:94—99, 1984
5. DISCHE F, WESTON M, PARSONS V: Abnormally thin glomerular
basement membranes associated with hematuria, proteinuria or renal
failure in adults. Am J Nephrol 5:103—109, 1985
6. ATKIN C, GREGORY M, BORDER W: Alport syndrome, in Diseases of
the Kidney, edited by SCHRIER 5, GOTSCHALK G, Boston/Toronto,
Little, Brown and Company, 1988, pp 617—641
7. TRYGGVASON K, ZHOU J, HOSTIKKA S, SHOWS T: Molecular genetics
of Alport syndrome. Kidney Ire 43:38—44, 1993
8. SMEETS H, LEMMINK H, NILLESEN W, VAN DRUNEN A, DEN HEUVEL
L, MONNENS L, SCHRODER C: Type IV collagen defects in Alport
syndrome and familial benign hematuria. (abstract) Kidney mt (in press)
9. TIEBOSCH A, WOLTERS J, FREDERIK P, VAN DE WIEL T, ZEPPENFELDT
F, VAN BREDA VRIESMAN P: Epidemiology of idiopathic glomerular
disease: A prospective study. Kidney mt 32:112—116, 1987
10. STEFFES M, BARBOSA J, BASGEN J, SUTHERLAND D, NAJARIAN J,
MAUER S: Quantitative morphology of the normal human kidney. Lab
Invest 49:82—86, 1983
11. BRUN C: A rapid method for the determination of para-aminhippurin
acid in kidney function test. J Lab Cliii Chem 3 7:955—98, 1951
12. ZnTAN L: Enzymatic hydrolysis of inulin. An alternative way to
fructose production. Storch/Starke 33:5373—5377, 1981
13. Editorial. Benign familial haematuria. Lancet i:549—550, 1988
14. SCHRODER C, BONTEMPS C, ASSMANN K, SCHUURMANS STEKHOVEN J,
FOIDART J, MONNENS L, VEERKAMP J: Renal biopsy and family studies
in 65 children with isolated hematuria. Acta Paediatr Scand 79:630—
636, 1990
15. LANG S, STEVENSON B, RISD0N R: Thin basement membrane ne-
phropathy as a cause of recurrent haematuria in childhood. Histopa-
thology 16:331—337, 1990
16. SAVIGE J: Hereditary abnormalities of renal basement membrane.
Pathology 23:350—355, 1991
17. BODZIAK K, HAMMOND W, M0LITORIS B: Inherited diseases of the
glomerular basement membrane. Am J Kidney Dis 23:605—618,
1994
18.SCIIENA F, Sci VITARRO V, RANIER! F: IgA nephropathy, pros and cons
for a familial disease. Contrib Nephrol 104:34—45, 1993
19. JOHNSTON P, DAVISON A: Hypertension in adults with idiopathic
glomerulonephritis and normal serum ereatinine. A report from the
MRC Glomerulonephritis Registry. Nephrol Dial Transplant 8:20—24,
1993
20. KAPLAN: Clinical Hypertension (6th Ed). Baltimore, Williams and
Wilkin, 1994
21. GOEL 5, DAVENPORT A, GOODE N, SHIRES M, HALL C, HARRISON P,
MACI VER A: Clinical features and outcome of patients with thin and
ultrathin glomerular membranes. Q J Med 88:785—793, 1995
22. FLINTER F, CAMERON J, CHANTI.ER C, HOUSTON I, BoRRow M:
Genetics of classical Alport's syndrome. Lancet ii:1005—1007, 1988
